Clinical Trials List
2022-08-31 - 2026-02-28
Phase III
Recruiting6
ICD-10C18.3
Malignant neoplasm of hepatic flexure
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.0
Malignant neoplasm of hepatic flexure colon
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃盈慈 未分科
- Peng-Chan Lin 未分科
- Po-Wen Lin 無
- Shang-Hung Chen 未分科
- Jui-Hung Tsai 未分科
- 陳柏全 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsai-Sheng Yang 無
- Mengting Peng 無
- 張境夫 無
- Jen-Shi Chen 無
- 黃文冠 無
- Wen-Chi Chou 無
- 余紹銘 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wei-Chih Su 未分科
- 蔡祥麟 無
- 黃敬文 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
28 participants
-
Global
901 participants
